Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × spartalizumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Colorectal Neoplasms 6 Stomach Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Solid Tumors 2 Solid Tumor 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Esophageal Squamous Cell Carcinoma 2 Breast Neoplasms 2 Advanced Solid Tumors 2 von Hippel-Lindau Disease 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1

Interventions

Carboplatin 8 pembrolizumab 6 Radiotherapy 5 Pemetrexed 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiation 4 Paclitaxel 3 Nivolumab 3 Cisplatin 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 aldesleukin 2 Taxes 2 Radiotherapy, Conformal 2 Platinum 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 veliparib 1 trametinib 1 sotorasib 1 rucaparib 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡